Biomerica (BMRA) Net Cash Flow Growth (3y) (2013 - 2026)
Biomerica (BMRA) Net Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.51 Bn | 174.21 Bn | 6.27 Bn | -32.51% |
| 2 | Stryker | 128.52 Bn | 125.64 Bn | 3.81 Bn | -87.87% |
| 3 | Medtronic | 108.06 Bn | 98.84 Bn | 6.41 Bn | 31.32% |
| 4 | Boston Scientific | 68.04 Bn | 66.59 Bn | 3.61 Bn | -11.49% |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | -87.88% |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn | -65.12% |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 129.29% |
| 8 | Smith & Nephew | 26.88 Bn | 26.30 Bn | - | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.29 Bn | 2.07 Bn | -48.90% |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 | 11.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 11.34% |
| Nov 30, 2025 | 20.16% |
| Aug 31, 2025 | 56.22% |
| May 31, 2025 | 46.05% |
| Feb 28, 2025 | -38.66% |
| Nov 30, 2024 | 26.79% |
| Aug 31, 2024 | -54.30% |
| May 31, 2024 | 0.18% |
| Feb 29, 2024 | -64.82% |
| Nov 30, 2023 | 12.60% |
| Aug 31, 2023 | -1.22% |
| May 31, 2023 | 0.66% |
| Feb 28, 2023 | -45.93% |
| Nov 30, 2022 | -189.18% |
| Aug 31, 2022 | 11.24% |
| May 31, 2022 | -164.93% |
| Feb 28, 2022 | 154.55% |
| Nov 30, 2021 | -78.57% |
| Aug 31, 2021 | 48.81% |
| May 31, 2021 | -55.43% |